Fulcrum Therapeutics, Inc. (FULC)
NASDAQ: FULC · Real-Time Price · USD
3.700
+0.200 (5.71%)
At close: Jun 18, 2026, 4:00 PM EDT
3.667
-0.034 (-0.91%)
After-hours: Jun 18, 2026, 7:15 PM EDT
Fulcrum Therapeutics Market Cap
Fulcrum Therapeutics has a market cap or net worth of $246.54 million as of June 18, 2026. Its market cap has decreased by -35.03% in one year.
Market Cap
246.54M
Enterprise Value
-80.91M
1-Year Change
-35.03%
Ranking
Category
Stock Price
$3.70
Market Cap Chart
Since July 18, 2019, Fulcrum Therapeutics's market cap has decreased from $301.64M to $246.54M, a decrease of -18.27%. That is a compound annual growth rate of -2.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 246.54M | -66.96% |
| Dec 31, 2025 | 746.12M | 194.32% |
| Dec 31, 2024 | 253.51M | -39.25% |
| Dec 29, 2023 | 417.30M | 10.13% |
| Dec 30, 2022 | 378.93M | -47.15% |
| Dec 31, 2021 | 716.95M | 124.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Foghorn Therapeutics | 237.79M |
| Adagene | 233.24M |
| NervGen Pharma | 232.58M |
| AC Immune | 232.13M |
| Cellectis | 231.09M |
| Orchestra BioMed Holdings | 230.84M |
| Sol-Gel Technologies | 230.01M |
| Cybin | 229.16M |